Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms

Exclusion Criteria

• •BMI \> 35kg/m2.
• •Any active comorbid disease, ECG or laboratory result deemed by the investigator to be clinically significant and which could impact safety during study conduct or that could interfere with the study evaluation, procedures or completion.
• •Use of prohibited medications defined in the protocol.
• •Inability or unwillingness to comply with study procedures or requirements.